Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Blueprint Medicines Corporation.
Blueprint Medicines Corporation business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Blueprint Medicines Corporation are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Blueprint Medicines Corporation , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Blueprint Medicines Corporation including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Blueprint Medicines Corporation and all latest updates of the company are provided.
The 2025 version of Blueprint Medicines Corporation report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Blueprint Medicines Corporation- Key Facts
2.2 Blueprint Medicines Corporation- Geographic Locations
2.3 Blueprint Medicines Corporation- Subsidiaries and Affiliates
2.4 Blueprint Medicines Corporation- Business Divisions
2.5 Blueprint Medicines Corporation- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Blueprint Medicines Corporation Strategic Analysis Review
3.1 Blueprint Medicines Corporation- Key Strategies
3.2 Blueprint Medicines Corporation- Company Outlook Statement
3.3 Blueprint Medicines Corporation- SWOT Analysis
3.3.1 Blueprint Medicines Corporation- Key Strengths
3.3.2 Blueprint Medicines Corporation- Key Weaknesses
3.3.3 Blueprint Medicines Corporation- Potential Opportunities
3.3.4 Blueprint Medicines Corporation- Potential Threats
3.4 Blueprint Medicines Corporation- Key Competitors
4. Business Description of the Company
4.1 Blueprint Medicines Corporation- Business Overview
4.2 Blueprint Medicines Corporation- Operations by Segment
5 Products and Services Details
5.1 Blueprint Medicines Corporation- Key Products
5.2 Blueprint Medicines Corporation- Key Service Areas
5.3 Blueprint Medicines Corporation- Key Brands
6 Company Developments
6.1 Blueprint Medicines Corporation- Company History
6.2 Blueprint Medicines Corporation- Latest Developments
7 Financial Analysis
7.1 Blueprint Medicines Corporation- Income Statements
7.2 Blueprint Medicines Corporation- Balance Sheet
7.3 Blueprint Medicines Corporation- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Blueprint Medicines Corporation- Direct Competitors
8.2 Blueprint Medicines Corporation- Competitor Financial Ratios comparison
8.3 Blueprint Medicines Corporation- Competitor Stock Charts Comparison
8.4 Blueprint Medicines Corporation- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!